Absorbed Dose Estimates After Bolus Injection of 11C-DPA-713
| Organ | mSv/MBq | rem/mCi | Percentage of coefficient of variation |
| Adrenals | 8.21E–03 | 3.04E–02 | 33.0 |
| Brain | 3.34E–03 | 1.24E–02 | 25.9 |
| Breasts | 2.07E–03 | 7.64E–03 | 21.1 |
| Gallbladder wall | 4.00E–03 | 1.48E–02 | 7.1 |
| Lower large intestine wall | 3.81E–03 | 1.41E–02 | 26.6 |
| Small intestine | 6.19E–03 | 2.29E–02 | 25.7 |
| Stomach | 4.72E–03 | 1.75E–02 | 9.1 |
| Upper large intestine wall | 4.92E–03 | 1.82E–02 | 50.7 |
| Heart | 9.32E–03 | 3.45E–02 | 42.3 |
| Kidneys | 1.17E–02 | 4.34E–02 | 24.7 |
| Liver | 9.19E–03 | 3.41E–02 | 18.3 |
| Lungs | 2.01E–02 | 7.43E–02 | 28.8 |
| Muscle | 2.53E–03 | 9.35E–03 | 15.3 |
| Ovaries | 3.88E–03 | 1.44E–02 | 28.3 |
| Pancreas | 1.12E–02 | 4.13E–02 | 36.2 |
| Red marrow | 3.86E–03 | 1.43E–02 | 23.7 |
| Bone surface | 4.71E–03 | 1.74E–02 | 23.6 |
| Skin | 1.96E–03 | 7.25E–03 | 16.7 |
| Spleen | 1.32E–02 | 4.87E–02 | 25.1 |
| Testes | 2.00E–03 | 7.39E–03 | 1.6 |
| Thymus | 2.99E–03 | 1.11E–02 | 13.8 |
| Thyroid | 6.04E–03 | 2.24E–02 | 29.0 |
| Urinary bladder wall | 2.37E–03 | 8.76E–03 | 12.2 |
| Uterus | 4.19E–03 | 1.55E–02 | 14.1 |
| Total | 3.23E–03 | 1.20E–02 | 12.4 |
| Effective dose equivalent | 7.67E–03 | 2.84E–02 | 19.9 |
| Effective dose | 5.93E–03 | 2.20E–02 | 17.0 |
Coefficient of variation is equal to SD divided by mean multiplied by 100. Values are averaged across all 6 subjects, except for breasts, uterus or uterine wall, testes, and ovaries, which are sex-specific and thus averaged across 3 subjects. Although ovaries were not identified in 1 female subject, OLINDA is still able to report absorbed dose estimate for that subject; estimate was included for computing average dose.